2024
Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach
Devine O, Pham H, Gunnels B, Reese H, Steele M, Couture A, Iuliano D, Sachdev D, Alden N, Meek J, Witt L, Ryan P, Reeg L, Lynfield R, Ropp S, Barney G, Tesini B, Shiltz E, Sutton M, Talbot H, Reyes I, Havers F. Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach. Influenza And Other Respiratory Viruses 2024, 18: e70026. PMID: 39440677, PMCID: PMC11497105, DOI: 10.1111/irv.70026.Peer-Reviewed Original Research
2023
Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022
Shah M, Patel K, Milucky J, Taylor C, Reingold A, Armistead I, Meek J, Anderson E, Weigel A, Reeg L, Como‐Sabetti K, Ropp S, Muse A, Bushey S, Shiltz E, Sutton M, Talbot H, Chatelain R, Havers F, Team T. Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022. Influenza And Other Respiratory Viruses 2023, 17: e13107. PMID: 36875205, PMCID: PMC9981874, DOI: 10.1111/irv.13107.Peer-Reviewed Original ResearchMeSH KeywordsAdultBacterial InfectionsCoinfectionCOVID-19HumansInfluenza, HumanSARS-CoV-2Virus DiseasesConceptsDay of admissionSARS-CoV-2 infectionHospitalized adultsViral infectionBacterial coinfectionCOVID-19Laboratory-confirmed SARS-CoV-2 infectionBacterial infectionsPopulation-based surveillance systemRhinovirus/enterovirusRespiratory syncytial virusBacterial pathogensCoV-2 virusClinical featuresClinical outcomesViral coinfectionSyncytial virusHuman metapneumovirusParainfluenza virusRisk factorsSterile sitesEndemic coronavirusesRelative riskRelevant bacterial pathogensGram-negative rods
2022
Characteristics and treatment of hospitalized pregnant women with COVID-19
Sekkarie A, Woodruff R, Whitaker M, Kramer M, Zapata L, Ellington S, Meaney-Delman D, Pham H, Patel K, Taylor C, Chai S, Kawasaki B, Meek J, Openo K, Weigel A, Leegwater L, Como-Sabetti K, Ropp S, Muse A, Bennett N, Billing L, Sutton M, Talbot H, Hill M, Havers F, Team C. Characteristics and treatment of hospitalized pregnant women with COVID-19. American Journal Of Obstetrics & Gynecology MFM 2022, 4: 100715. PMID: 35970493, PMCID: PMC9371979, DOI: 10.1016/j.ajogmf.2022.100715.Peer-Reviewed Original ResearchConceptsSymptomatic COVID-19Pregnant womenSystemic steroidsCOVID-19 vaccinationVaccination statusPregnant patientsNonpregnant womenCOVID-19Laboratory-confirmed SARS-CoV-2 infectionPregnancy statusPropensity score-matched cohortCOVID-19-Associated Hospitalization Surveillance NetworkSARS-CoV-2 infectionMedical chart abstractionTreatment-eligible patientsAdverse pregnancy outcomesSymptomatic pregnant womenCOVID-19 vaccination statusHospitalized pregnant womenNon-Hispanic blacksImplementation of treatmentHospitalized womenChart abstractionClinical characteristicsPregnancy outcomesHospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
Shi D, Whitaker M, Marks K, Anglin O, Milucky J, Patel K, Pham H, Chai S, Kawasaki B, Meek J, Anderson E, Weigel A, Henderson J, Lynfield R, Ropp S, Muse A, Bushey S, Billing L, Sutton M, Talbot H, Price A, Taylor C, Havers F, Team C. Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022. MMWR Morbidity And Mortality Weekly Report 2022, 71: 574-581. PMID: 35446827, PMCID: PMC9042359, DOI: 10.15585/mmwr.mm7116e1.Peer-Reviewed Original ResearchMeSH KeywordsBNT162 VaccineChildCOVID-19EthnicityHospitalizationHumansMinority GroupsSARS-CoV-2United StatesConceptsCOVID-19-associated hospitalizationCOVID-19-Associated Hospitalization Surveillance NetworkIntensive care unitAge groupsUnvaccinated childrenPfizer-BioNTech COVID-19 vaccineCumulative hospitalization rateNon-Hispanic black childrenSevere COVID-19Immunization Practices recommendationsUnderlying medical conditionsCDC's Advisory CommitteeImportance of vaccinationEmergency use authorizationUnderlying health conditionsCOVID-19 vaccineCOVID-19SARS-CoV-2Advisory CommitteeCare unitHospitalization ratesVaccination coverageSevere outcomesChildren Aged 5Medical conditions
2021
Risk Factors for Severe COVID-19 in Children
Woodruff R, Campbell A, Taylor C, Chai S, Kawasaki B, Meek J, Anderson E, Weigel A, Monroe M, Reeg L, Bye E, Sosin D, Muse A, Bennett N, Billing L, Sutton M, Talbot H, McCaffrey K, Pham H, Patel K, Whitaker M, McMorrow M, Havers F. Risk Factors for Severe COVID-19 in Children. Pediatrics 2021, 149: e2021053418. PMID: 34935038, PMCID: PMC9213563, DOI: 10.1542/peds.2021-053418.Peer-Reviewed Original ResearchConceptsSevere COVID-19Adjusted risk ratioPopulation-based ratesHospitalized childrenRisk factorsCOVID-19Laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infectionAcute respiratory syndrome coronavirus 2 infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionSyndrome coronavirus 2 infectionSevere coronavirus disease 2019COVID-19-Associated Hospitalization Surveillance NetworkNon-Hispanic black childrenCoronavirus 2 infectionChronic lung diseaseConfidence intervalsCoronavirus disease 2019COVID-19 vaccineTube dependenceAirway abnormalitiesDiabetes mellitusIllness severityLung diseaseRisk ratioMedical records